Stockscreener 앱 받기
7.13
2.33%
-0.17
시장 영업 전:
7.20
0.07
+0.98%
전일 마감가:
$7.30
열려 있는:
$7.3
하루 거래량:
5.86M
Relative Volume:
1.53
시가총액:
$1.76B
수익:
$407.32M
순이익/손실:
$-61.60M
주가수익비율:
-27.68
EPS:
-0.2576
순현금흐름:
$-43.98M
1주 성능:
+19.43%
1개월 성능:
+20.03%
6개월 성능:
+19.83%
1년 성능:
+90.90%
1일 변동 폭
$6.94
$7.425
1주일 범위
$5.82
$7.43
52주 변동 폭
$3.21
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
7.13 | 1.76B | 407.32M | -61.60M | -43.98M | -0.2576 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | 재개 | Raymond James | Strong Buy |
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-05-02 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | 재개 | Ladenburg Thalmann | Buy |
| 2025-03-04 | 개시 | BTIG Research | Buy |
| 2024-11-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-18 | 개시 | Raymond James | Strong Buy |
| 2023-09-07 | 개시 | H.C. Wainwright | Buy |
| 2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-03-23 | 개시 | Wedbush | Outperform |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 재개 | Citigroup | Buy |
| 2020-02-18 | 재개 | Jefferies | Buy |
| 2020-02-12 | 개시 | Citigroup | Buy |
| 2020-02-10 | 개시 | Cowen | Outperform |
| 2019-04-08 | 개시 | Piper Jaffray | Overweight |
| 2018-08-24 | 개시 | Jefferies | Buy |
| 2018-03-19 | 재개 | Leerink Partners | Outperform |
| 2017-11-29 | 재확인 | Citigroup | Buy |
| 2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
| 2017-10-17 | 재개 | Leerink Partners | Outperform |
| 2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
| 2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
| 2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan
Ardelyx (NASDAQ:ARDX) Strengthens Amid Biotech Momentum - Kalkine Media
Ardelyx, Inc. (NASDAQ:ARDX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - 富途牛牛
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st
Ardelyx reiterates 2026 guidance as IBSRELA targets $1B in 2029 while advancing ACCEL CIC Phase III enrollment by year-end - MSN
A Look At Ardelyx (ARDX) Valuation After Strong Q1 Results And Updated 2026 Guidance - simplywall.st
Analyst Estimates: Here's What Brokers Think Of Ardelyx, Inc. (NASDAQ:ARDX) After Its First-Quarter Report - Yahoo Finance
AIGH Capital Management LLC Purchases 951,500 Shares of Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx Projects $1 Billion Revenue for Ibsrela by 2029 - HarianBasis.co
Ardelyx Earnings Call: Ibsrela Surge Fuels Bold Targets - TipRanks
Piper Sandler Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Ardelyx Posts Strong Q1 2026 Revenue, Reaffirms Guidance - The Globe and Mail
Ardelyx (ARDX) Is Up 6.2% After Revenue Rises And Loss Narrows As New CLO Joins - simplywall.st
Ardelyx | 8-K: Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update - Moomoo
Ardelyx | 10-Q: Q1 2026 Earnings Report - Moomoo
Ardelyx (NASDAQ:ARDX) Shares Gap Down After Earnings Miss - MarketBeat
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2026 Earnings Call Transcript - Insider Monkey
Ardelyx (ARDX) Q1 2026 Earnings Transcript - AOL.com
Analyst Reiterates Buy on Ardelyx, Citing Tenapanor Momentum and Pipeline Upside with Unchanged $18 Price Target - TipRanks
MSN Money - MSN
Earnings Call Summary | Ardelyx(ARDX.US) Q1 2026 Earnings Conference - Moomoo
Ardelyx (NASDAQ:ARDX) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Ardelyx, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Ardelyx (ARDX) Reports Strong Q1 Revenue and Strategic Developme - GuruFocus
ARDX: Q1 revenue up 38% year-over-year, driven by IBSRELA and XPHOZAH growth, with guidance reaffirmed - TradingView
Ardelyx (ARDX) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Ardelyx (ARDX) Reports Mixed Q1 Earnings with Revenue Beat - GuruFocus
Ardelyx Q1 Earnings Call Highlights - Yahoo Finance
Compared to Estimates, Ardelyx (ARDX) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
ARDX: Q1 2026 delivered robust 38% revenue growth, driven by IBSRELA and XPHOZAH performance - TradingView
Is Ardelyx (ARDX) Undervalued After Q1 2026? GAAP EPS -$0.15 Mis - GuruFocus
Earnings call transcript: Ardelyx Q1 2026 misses forecasts but shows growth - Investing.com India
Earnings Flash (ARDX) Ardelyx Posts Q1 EPS -$0.15, vs. FactSet Est of -$0.14 - marketscreener.com
Ardelyx Inc (NASDAQ:ARDX) Reports Strong Q1 Revenue Beat as IBSRELA Momentum Accelerates - ChartMill
ARDELYX ($ARDX) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (ARDX) Ardelyx, Inc. Reports Q1 Revenue $94.5M - marketscreener.com
Ardelyx: Q1 Earnings Snapshot - Barchart
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Ardelyx says IBSRELA sales hit $70.1M as it funds new trials - Stock Titan
ARDELYX, INC. 1Q 2026: Revenue $94.5M, EPS $(0.15) — 10-Q Summary - TradingView
Ardelyx (NASDAQ: ARDX) grows Q1 2026 sales but remains unprofitable - Stock Titan
Ardelyx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Fast-growing Ardelyx (NASDAQ: ARDX) lifts Q1 revenue and reiterates strong 2026 guidance - Stock Titan
Ardelyx 1Q Loss/Shr 15c >ARDX - Moomoo
Ardelyx Target of Unusually Large Options Trading (NASDAQ:ARDX) - MarketBeat
Ardelyx earnings on deck: Can IBSRELA growth offset losses? By Investing.com - Investing.com Nigeria
Ardelyx earnings on deck: Can IBSRELA growth offset losses? - Investing.com UK
Ardelyx Inc (ARDX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments By GuruFocus - Investing.com Canada
Ardelyx gains after insider purchase, LPGA marketing deal - MSN
New equity plan shares and pay votes at Ardelyx (NASDAQ: ARDX) 2026 meeting - Stock Titan
ARDX Q1'26 Earnings: EPS estimate is (0.14) USD - TradingView
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):